1.
|
B BrennanNasopharyngeal carcinomaOrphanet
J Rare Dis123200610.1186/1750-1172-1-23
|
2.
|
S AfqirN IsmailiH ErrihaniConcurrent
chemoradiotherapy in the management of advanced nasopharyngeal
carcinoma: current statusJ Can Res
Ther537200910.4103/0973-1482.4876319293481
|
3.
|
RA AlbiruniRazakL LillianFF LiuE ItoB
O’SullivanK ChanNasopharyngeal carcinoma: the next challengesEur J
Cancer4619671978201010.1016/j.ejca.2010.04.004
|
4.
|
SM ChenJP LiuJX ZhouSuppression of the
notch signaling pathway by γ-secretase inhibitor GSI inhibits human
nasopharyngeal carcinoma cell proliferationCancer
Lett30676842011
|
5.
|
J GuigayAdvances in nasopharyngeal
carcinomaCurr Opin
Oncol20264269200810.1097/CCO.0b013e3282fad84618391624
|
6.
|
HM LuaLX PangXB YuanConcurrent
chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a
treatment paradigm also applicable to patients in Southeast
AsiaCancer Treat
Rev35345353200910.1016/j.ctrv.2009.01.00219211192
|
7.
|
M KartalouJM EssigmannMechanisms of
resistance to CisplatinMutat
Res4782343200110.1016/S0027-5107(01)00141-511406167
|
8.
|
F GuY MaZ ZhangJ ZhaoH KobayashiL ZhangL
FuExpression of Stat3 and Notch1 is associated with cisplatin
resistance in head and neck squamous cell carcinomaOncol
Rep23671676201020127005
|
9.
|
ZW WangYW LiA AhmadTargeting Notch
signaling pathway to overcome drug resistance for cancer
therapyBiochim Biophys Acta182582672010
|
10.
|
S Artavanis-TsakonasMD RandRJ LakeNotch
signaling: cell fate control and signal integration in
developmentScience284770776199910.1126/science.284.5415.77010221902
|
11.
|
T KadeschNotch signaling: the demise of
elegant simplicityCurr Opin
Genet14506512200410.1016/j.gde.2004.07.00715380241
|
12.
|
R KopanMX IlaganThe canonical Notch
signaling pathway: unfolding the activation
mechanismCell137216233200910.1016/j.cell.2009.03.04519379690
|
13.
|
IM ShihTL WangNotch signaling, γ-secretase
inhibitors, and cancer therapyCancer Res67187918822007
|
14.
|
J SarahNotch signaling: a simple pathway
becomes complexNat Rev Mol Cell
Biol7678687200610.1038/nrm200916921404
|
15.
|
T AleksicM StephanGamma-secretase
inhibition combined with platinum compounds enhances cell death in
a large subset of colorectal cancer cellsCell Commun
Signal6113200810.1186/1478-811X-6-818950493
|
16.
|
G SzakacsJK PatersonJA LudwigC
Booth-GentheMM GottesmanTargeting multidrug resistance in cancerNat
Rev Drug Discov5219234200610.1038/nrd198416518375
|
17.
|
MM GottesmanMechanisms of cancer drug
resistanceAnn Rev
Med5615627200210.1146/annurev.med.53.082901.103929
|
18.
|
Z WangY LiD KongA AhmadS BanerjeeFH
SarkarCross-talk between miRNA and Notch signaling pathways in
tumor development and progressionCancer
Lett292141148201010.1016/j.canlet.2009.11.01220022691
|
19.
|
Z WangY LiS BanerjeeFH SarkarEmerging role
of Notch in stem cells and cancerCancer
Lett279812200910.1016/j.canlet.2008.09.03019022563
|
20.
|
LL SuC Yan-ChengD DoloresDrug transporter,
P-glycoprotein (MDR1), is an integrated component of the mammalian
blood-testis barrierInt J Biochem Cell
Biol4125782587200910.1016/j.biocel.2009.08.01519720156
|
21.
|
XB ChangA molecular understanding of
ATP-dependent solute transport by multidrug resistance-associated
protein MRP1Cancer Metastasis
Rev261537200710.1007/s10555-007-9041-717295059
|
22.
|
Y HuangX YangY Wuγ-secretase inhibitor
induces adipogenesis of adipose-derived stem cells by regulation of
Notch and PPAR-γCell Prolif431471562010
|
23.
|
L BorgheseD DolezalovaT OpitzInhibition of
Notch signaling in human embryonic stem cell-derived neural stem
cells delays G1/S phase transition and accelerates neuronal
differentiation in vitro and in vivoStem
Cells28955964201010.1002/stem.40820235098
|
24.
|
RL FineTC ChambersCW SachsP-glycoprotein,
multidrug resistance and protein kinase CStem
Cells144755199610.1002/stem.1400478820951
|
25.
|
K KirschnerDW MeltonMultiple roles of the
ERCC1-XPF endonuclease in DNA repair and resistance to anticancer
drugsAnticancer Res3032233232201020944091
|
26.
|
J BellmuntL Paz-AresM CuelloGene
expression of ERCC1 as a novel prognostic marker in advanced
bladder cancer patients receiving cisplatin-based chemotherapyAnn
Oncol18522528200710.1093/annonc/mdl43517229776
|
27.
|
KA OlaussenA DunantP FouretDNA repair by
ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant
chemotherapyN Engl J
Med355983991200610.1056/NEJMoa06057016957145
|
28.
|
QE WangK MilumCH HanDifferential
contributory roles of nucleotide excision and homologous
recombination repair for enhancing cisplatin sensitivity in human
ovarian cancer cellsMol Cancer1024201110.1186/1476-4598-10-24
|
29.
|
Y NefedovaM DanielCB SophiaSD WilliamIG
DmitryInhibition of Notch signaling induces apoptosis of myeloma
cells and enhances sensitivity to
chemotherapyBlood11122202228200810.1182/blood-2007-07-10263218039953
|
30.
|
S KoduruR KumarS SrinivasanNotch-1
inhibition by Withaferin-A: a therapeutic target against colon
carcinogenesisMol Cancer
Ther9202210201010.1158/1535-7163.MCT-09-077120053782
|